Journal
LETTERS IN APPLIED MICROBIOLOGY
Volume 73, Issue 6, Pages 718-724Publisher
OXFORD UNIV PRESS
DOI: 10.1111/lam.13560
Keywords
antimicrobials; diseases; pharmaceuticals; resistance; yeasts
Categories
Funding
- Deanship of Scientific Research, The University of Jordan, Amman-Jordan
Ask authors/readers for more resources
The study found that silver nanoparticles enhance the antifungal ability of fluconazole, reduce the concentration of fluconazole, and provide a promising method for the treatment of Candida glabrata infections.
Resistance to azole antifungal agents is a challenging limitation in Candida glabrata treatment. It is associated with decreased intracellular concentrations of antifungal agents as a result of overexpression of efflux pumps on the cellular plasma membranes. This work evaluates the potential of silver nanoparticles (AgNPs) to reverse the resistance of fungal cells to fluconazole. Silver nanoparticles were prepared using wet chemical method and characterised by UV-Vis spectrophotometry, dynamic light scattering, and zeta potential. Broth microdilution and pour plates methods were used to study the anticandidal activity using two C. glabrata fluconazole-resistant strains (DSY565 and CBS138) known to overexpress active efflux pumps, and a standard fluconazole sensitive strain ATCC 22553. Silver nanoparticles-fluconazole combinations decreased concentrations of fluconazole substantially without compromising the activity. These findings suggest that AgNPs enhance the efficacy of fluconazole and offer a promising application in therapy of C. glabrata infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available